IBA signs three new ProteusONE contracts with Proton Partners International

IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three new contracts with Proton Partners International (PPI), to install three Proteus┬«ONE compact proton therapy solutions across the UK. The contracts are subject to financing.
DotMed